Marianne Rissler
21 – 30 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
- Contribution to journal › Article
- 2014
-
Mark
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.
- Contribution to journal › Letter
-
Mark
Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.
- Contribution to journal › Article
- 2013
-
Mark
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
- Contribution to journal › Article
-
Mark
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
- Contribution to journal › Article
- 2012
-
Mark
Whole-exome sequencing of pediatric acute lymphoblastic leukemia.
- Contribution to journal › Article
- 2011
-
Mark
SMAD4 binds HOXA9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by HOXA9 and leukemia transformation.
- Contribution to journal › Article
- 2010
-
Mark
Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice
- Contribution to journal › Article
-
Mark
SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation
(2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1297-1298
- Contribution to journal › Published meeting abstract
-
Mark
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
- Contribution to journal › Article
